• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,142
110
76
72
69

COUNTRY

71
22
16
10
9

CATEGORIES

  • 575
  • 121
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

1,047
1,292
2,048
3,059

PUBLISHED

79
253
700
3,059

PRODUCT TYPE

2,431
494
69
62
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Malignant Pleural Mesothelioma - Pipeline Review, H2 2014

Malignant Pleural Mesothelioma - Pipeline Review, H2 2014 Summary This, ‘Malignant Pleural Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic...

July 2014
FROM

Brain Metastasis - Pipeline Review, H2 2014

Brain Metastasis - Pipeline Review, H2 2014 Summary This, ‘Brain Metastasis - Pipeline Review, H2 2014’, provides an overview of the Brain Metastasis’s therapeutic pipeline. This report provides...

July 2014
FROM

Peritoneal Cancer - Pipeline Review, H2 2014

Peritoneal Cancer - Pipeline Review, H2 2014 Summary This, ‘Peritoneal Cancer - Pipeline Review, H2 2014’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This report provides...

July 2014
FROM

Mantle Cell Lymphoma - Pipeline Review, H2 2014

Mantle Cell Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This report...

July 2014
FROM

Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2014

Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Metastatic Renal Cell Carcinoma’s...

July 2014
FROM

Bladder Cancer - Pipeline Review, H2 2014

Bladder Cancer - Pipeline Review, H2 2014 Summary This, ‘Bladder Cancer - Pipeline Review, H2 2014’, provides an overview of the Bladder Cancer’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)...

July 2014
FROM

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 Summary This, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014’, provides an overview of the Relapsed...

July 2014
FROM

Refractory Multiple Myeloma - Pipeline Review, H2 2014

Refractory Multiple Myeloma - Pipeline Review, H2 2014 Summary This, ‘Refractory Multiple Myeloma - Pipeline Review, H2 2014’, provides an overview of the Refractory Multiple Myeloma’s therapeutic...

July 2014
FROM

Nasopharyngeal Cancer - Pipeline Review, H2 2014

Nasopharyngeal Cancer - Pipeline Review, H2 2014 Summary This, ‘Nasopharyngeal Cancer - Pipeline Review, H2 2014’, provides an overview of the Nasopharyngeal Cancer’s therapeutic pipeline. This report...

July 2014
FROM

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic...

July 2014
FROM

Metastatic Colorectal Cancer - Pipeline Review, H2 2014

Metastatic Colorectal Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Colorectal Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Colorectal Cancer’s therapeutic...

July 2014
FROM

Myelodysplastic Syndrome - Pipeline Review, H2 2014

Myelodysplastic Syndrome - Pipeline Review, H2 2014 Summary This, ‘Myelodysplastic Syndrome - Pipeline Review, H2 2014’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline. This...

July 2014
FROM

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across the leading eight developed nations, from $5 1 billion in 2013 to $7...

July 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H2 2014

Small-Cell Lung Cancer - Pipeline Review, H2 2014 Summary This, ‘Small-Cell Lung Cancer - Pipeline Review, H2 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline. This...

July 2014
FROM

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Exceptionally Large and Innovative Pipeline: The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms...

July 2014
FROM

Neuroblastoma - Pipeline Review, H2 2014

Neuroblastoma - Pipeline Review, H2 2014 Summary This, ‘Neuroblastoma - Pipeline Review, H2 2014’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM
Hyaluronan Signaling and Turnover, Vol 123 Hyaluronan Signaling and Turnover, Vol 123 - Product Thumbnail Image

Hyaluronan Signaling and Turnover, Vol 123

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of...

July 2014

Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report

The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact...

July 2014
Electroporation-Based Therapies for Cancer. Woodhead Publishing Series in Biomedicine Electroporation-Based Therapies for Cancer. Woodhead Publishing Series in Biomedicine - Product Thumbnail Image

Electroporation-Based Therapies for Cancer. Woodhead Publishing Series in Biomedicine

Electroporation-Based Therapies for Cancer reviews electroporation-based clinical studies in hospitals for various cancer treatments, including melanomas, head and neck cancers, chest wall breast carcinomas,...

July 2014
Loading Indicator

Our Clients

Our clients' logos